Enhancement of skin permeation of bufalin by limonene via reservoir type transdermal patch: Formulation design and biopharmaceutical evaluation

International Journal of Pharmaceutics

Volumn 447, Issue 1-2, 2013, Pages 231-240

  Yang, Zhen ^a,b   Teng, Yang ^b   Wang, Hao ^b   Hou, Huimin ^b  

^a UNIVERSITY OF HOUSTON   (United States)

^b National Pharmaceutical Engineering Research Center   (China)

Author keywords

Biopharmaceutics; Bufalin; d Limonene; Deconvolution; Pharmacokinetics; Transdermal delivery system

Indexed keywords

BUFALIN; ETHYLENE VINYL ACETATE COPOLYMER; LIMONENE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG DESIGN; DRUG DOSAGE FORM COMPARISON; DRUG FORMULATION; DRUG PENETRATION; DRUG RELEASE; DRUG SCREENING; DRUG STORAGE; DRUG STRUCTURE; HAIRLESS MOUSE; IN VITRO STUDY; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT; SKIN IRRITATION; SKIN PENETRATION; SUSTAINED DRUG RELEASE; TRANSDERMAL PATCH;

ACRYLATES; ADMINISTRATION, CUTANEOUS; ANIMALS; ANTINEOPLASTIC AGENTS; BUFANOLIDES; CHEMISTRY, PHARMACEUTICAL; CYCLOHEXENES; DRUG DELIVERY SYSTEMS; ETHANOL; MALE; MEMBRANES, ARTIFICIAL; MICE; MICE, HAIRLESS; MODELS, BIOLOGICAL; POLYVINYLS; PROPYLENE GLYCOL; RATS; RATS, SPRAGUE-DAWLEY; SKIN; SKIN ABSORPTION; TERPENES; TRANSDERMAL PATCH;

EID: 84875357896     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2013.02.048     Document Type: Article

References (41)

1. C. Amnuaikit, I. Ikeuchi, K. Ogawara, K. Higaki, and T. Kimura Skin permeation of propranolol from polymeric film containing terpene enhancers for transdermal use? Int. J. Pharm. 289 2005 167 178
2. R.J. Babu, and J.K. Pandit Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems Int. J. Pharm. 288 2005 325 334
3. H. Bozdogan Akaike's information criterion and recent developments in information complexity J. Math. Psychol. 44 2000 62 91
4. Y. Dong, S. Yin, J. Li, C. Jiang, M. Ye, and H. Hu Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway Apoptosis 16 2011 394 403
5. B.J. Drakulic, I.O. Juranic, S. Eric, and M. Zloh Role of complexes formation between drugs and penetration enhancers in transdermal delivery? Int. J. Pharm. 363 2008 40 49
6. FDA Part 182 SUBSTANCES GENERALLY RECOGNIZED AS SAFE. In: www.fda.gov/Food/./GenerallyRecognizedasSafeGRAS/default.htm.
7. L. Fox, M. Gerber, J. Plessis, and J. Hamman Transdermal drug delivery enhancement by compounds of natural origin Molecules 16 2011 10507 10540
8. R. Gannu, C.R. Palem, V.V. Yamsani, S.K. Yamsani, and M.R. Yamsani Enhanced bioavailability of lacidipine via microemulsion based transdermal gels: formulation optimization, ex vivo and in vivo characterization Int. J. Pharm. 388 2010 231 241
9. T. Ghafourian, P. Zandasrar, H. Hamishekar, and A. Nokhodchi The effect of penetration enhancers on drug delivery through skin: a QSAR study J. Control. Release 99 2004 113 125
10. S. Hashimoto, Y. Jing, N. Kawazoe, Y. Masuda, S. Nakajo, and T. Yoshida Bufalin reduces the level of topoisomerase II in human leukemia cells and affects the cytotoxicity of anticancer drugs Leuk. Res. 21 1997 875 883
11. S.H. Hong, and Y.H. Choi Bufalin induces apoptosis through activation of both the intrinsic and extrinsic pathways in human bladder cancer cells Oncol. Rep. 27 2012 114 120
12. Z. Hong, K. Chan, and H.W. Yeung Simultaneous determination of bufadienolides in the traditional Chinese medicine preparation, liu-shen-wan, by liquid chromatography J. Pharm. Pharmacol. 44 1992 1023 1026
13. N. Kawazoe, M. Watabe, Y. Masuda, S. Nakajo, and K. Nakaya Tiam1 is involved in the regulation of bufalin-induced apoptosis in human leukemia cells Oncogene 18 1999 2413 2421
14. Y.S. Krishnaiah, V. Satyanarayana, and P. Bhaskar Effect of limonene on the in vitro permeation of nicardipine hydrochloride across the excised rat abdominal skin Pharmazie 57 2002 842 847
15. D. Li, X. Qu, K. Hou, Y. Zhang, Q. Dong, and Y. Teng PI3K/Akt is involved in bufalin-induced apoptosis in gastric cancer cells Anticancer Drugs 20 2009 59 64
16. D. Liu, and J.F. Feng Determination of apparent aqueous solubility and apparent oil-water partition coefficients of three bufadienolides composition Zhongguo Zhong Yao Za Zhi 33 2008 1256 1258
17. Y. Liu, Z.Q. Chen, X. Zhang, N.P. Feng, J.H. Zhao, and S. Wu An improved formulation screening and optimization method applied to the development of a self-microemulsifying drug delivery system Chem. Pharm. Bull. (Tokyo) 58 2010 16 22
18. Y. Liu, P. Wang, C. Sun, J. Zhao, Y. Du, and F. Shi Bioadhesion and enhanced bioavailability by wheat germ agglutinin-grafted lipid nanoparticles for oral delivery of poorly water-soluble drug bufalin Int. J. Pharm. 419 2011 260 265
19. Z. Meng, P. Yang, Y. Shen, W. Bei, Y. Zhang, and Y. Ge Pilot study of huachansu in patients with hepatocellular carcinoma, nonsmall-cell lung cancer, or pancreatic cancer Cancer 115 2009 5309 5318
20. R. Panchagnula, P.S. Salve, N.S. Thomas, A.K. Jain, and P. Ramarao Transdermal delivery of naloxone: effect of water, propylene glycol, ethanol and their binary combinations on permeation through rat skin Int. J. Pharm. 219 2001 95 105
21. N.S. Panesar Bufalin and unidentified substance(s) in traditional Chinese medicine cross-react in commercial digoxin assay Clin. Chem. 38 1992 2155 2156
22. K.S. Paudel, M. Milewski, C.L. Swadley, N.K. Brogden, P. Ghosh, and A.L. Stinchcomb Challenges and opportunities in dermal/transdermal delivery Ther. Deliv. 1 2010 109 131
23. T.J. Qin, X.H. Zhao, J. Yun, L.X. Zhang, Z.P. Ruan, and B.R. Pan Efficacy and safety of gemcitabine-oxaliplatin combined with huachansu in patients with advanced gallbladder carcinoma World J. Gastroenterol. 14 2008 5210 5216
24. H. Song, T. Guo, K. Bi, H. Wang, and R. Zhang Determination of resibufogenin and cinobufagin in heart-protecting musk pill by HPLC Biomed. Chromatogr. 14 2000 130 132
25. L. Sun, D. Cun, B. Yuan, H. Cui, H. Xi, and L. Mu Formulation and in vitro/in vivo correlation of a drug-in-adhesive transdermal patch containing azasetron J. Pharm. Sci. 101 2012 4540 4548
26. H. Takeuchi, Y. Mano, S. Terasaka, T. Sakurai, A. Furuya, and H. Urano Usefulness of rat skin as a substitute for human skin in the in vitro skin permeation study Exp. Anim. 60 2011 373 384
27. H.K. Vaddi, P.C. Ho, Y.W. Chan, and S.Y. Chan Terpenes in ethanol: haloperidol permeation and partition through human skin and stratum corneum changes? J. Control. Release 81 2002 121 133
28. L. Wang, U. Raju, L. Milas, D. Molkentine, Z. Zhang, and P. Yang Huachansu, containing cardiac glycosides, enhances radiosensitivity of human lung cancer cells Anticancer Res. 31 2011 2141 2148
29. S.W. Wang, Y.C. Chiao, S.C. Tsai, C.C. Lu, J.J. Chen, and H.C. Shih Inhibition of bufalin on pituitary and testicular function in rats J. Pharmacol. Exp. Ther. 283 1997 528 532
30. A.C. Williams, and B.W. Barry Penetration enhancers Adv. Drug Deliv. Rev. 56 2004 603 618
31. A.C. Williams, and B.W. Barry Terpenes and the lipid-protein-partitioning theory of skin penetration enhancement Pharm. Res. 8 1991 17 24
32. S. Yan, X. Qu, C. Xu, Z. Zhu, L. Zhang, and L. Xu Down-regulation of Cbl-b by bufalin results in up-regulation of DR4/DR5 and sensitization of TRAIL-induced apoptosis in breast cancer cells J. Cancer Res. Clin. Oncol. 138 2012 1279 1289
33. Z. Yang, H. Luo, H. Wang, and H. Hou Preparative isolation of bufalin and cinobufagin from Chinese traditional medicine ChanSu J. Chromatogr. Sci. 46 2008 81 85
34. Z. Yang, W. Zhu, S. Gao, H. Xu, B. Wu, and K. Kulkarni Simultaneous determination of genistein and its four phase II metabolites in blood by a sensitive and robust UPLC-MS/MS method: application to an oral bioavailability study of genistein in mice J. Pharm. Biomed. Anal. 53 2010 81 89
35. J.Y. Yeh, W.J. Huang, S.F. Kan, and P.S. Wang Effects of bufalin and cinobufagin on the proliferation of androgen dependent and independent prostate cancer cells Prostate 54 2003 112 124
36. P. Yin, Y. Wang, Y. Qiu, L. Hou, X. Liu, and J. Qin Bufalin-loaded mPEG-PLGA-PLL-cRGD nanoparticles: preparation, cellular uptake, tissue distribution, and anticancer activity Int. J. Nanomed. 7 2012 3961 3969
37. C.H. Yu, S.F. Kan, H.F. Pu, E. Jea Chien, and P.S. Wang Apoptotic signaling in bufalin- and cinobufagin-treated androgen-dependent and -independent human prostate cancer cells Cancer Sci. 99 2008 2467 2476
38. D.M. Zhang, J.S. Liu, M.K. Tang, A. Yiu, H.H. Cao, and L. Jiang Bufotalin from Venenum Bufonis inhibits growth of multidrug resistant HepG2 cells through G(2)/M cell cycle arrest and apoptosis Eur. J. Pharmacol. 692 2012 19 28
39. L. Zhang, K. Nakaya, T. Yoshida, and Y. Kuroiwa Induction by bufalin of differentiation of human leukemia cells HL60, U937, and ML1 toward macrophage/monocyte-like cells and its potent synergistic effect on the differentiation of human leukemia cells in combination with other inducers Cancer Res. 52 1992 4634 4641
40. Z. Zhu, H. Sun, G. Ma, Z. Wang, E. Li, and Y. Liu Bufalin induces lung cancer cell apoptosis via the inhibition of PI3K/Akt pathway Int. J. Mol. Sci. 13 2012 2025 2035
41. S. Zorin, F. Kuylenstierna, and H. Thulin In vitro test of nicotine's permeability through human skin. Risk evaluation and safety aspects Ann. Occup. Hyg. 43 1999 405 413